Medicare and Insurance Policy Updates in 2023 Will Improve Cancer Screening Access by Removing Patient Colonoscopy Cost Following a Positive Cologuard Test
Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, supports recent policy changes that help increase access to recommended non-invasive colorectal cancer screening tests.
Recent News & Updates
Pancreatic cancer screening is not recommended for the general population due to its low incidence, leading to later diagnoses after symptoms already have appeared at an advanced stage.
Deaths linked to the 13 types of obesity-related cancer rose to 13.5 deaths per million from 3.7 deaths per million between 1999 and 2020, researchers reported Sunday at the Endocrine Society’s annual meeting in San Francisco.
Recently, a long-standing patient came in for her routine office follow-up appointment for management of hypertension and arthritis.
The Community Oncology Alliance (COA) strongly supports the “PBM Reform Act,” a new reform package introduced today by Rep. Buddy Carter (R-GA-1) and a bipartisan group of lawmakers that takes direct aim at the entrenched practices of pharmacy benefit managers (PBMs) driving up drug costs and undermining care for patients with cancer and other serious conditions.
